RT Journal Article
SR Electronic
T1 Deep learning Enables Accurate Diagnosis of Novel Coronavirus (COVID-19) with CT images
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2020.02.23.20026930
DO 10.1101/2020.02.23.20026930
A1 Song Ying
A1 Shuangjia Zheng
A1 Liang Li
A1 Xiang Zhang
A1 Xiaodong Zhang
A1 Ziwang Huang
A1 Jianwen Chen
A1 Huiying Zhao
A1 Ruixuan Wang
A1 Yutian Chong
A1 Jun Shen
A1 Yunfei Zha
A1 Yuedong Yang
YR 2020
UL http://medrxiv.org/content/early/2020/02/25/2020.02.23.20026930.abstract
AB Background A novel coronavirus (COVID-19) has emerged recently as an acute respiratory syndrome. The outbreak was originally reported in Wuhan, China, but has subsequently been spread world-widely. As the COVID-19 continues to spread rapidly across the world, computed tomography (CT) has become essentially important for fast diagnoses. Thus, it is urgent to develop an accurate computer-aided method to assist clinicians to identify COVID-19-infected patients by CT images.Materials and Methods We collected chest CT scans of 88 patients diagnosed with the COVID-19 from hospitals of two provinces in China, 101 patients infected with bacteria pneumonia, and 86 healthy persons for comparison and modeling. Based on the collected dataset, a deep learning-based CT diagnosis system (DeepPneumonia) was developed to identify patients with COVID-19.Results The experimental results showed that our model can accurately identify the COVID-19 patients from others with an excellent AUC of 0.99 and recall (sensitivity) of 0.93. In addition, our model was capable of discriminating the COVID-19 infected patients and bacteria pneumonia-infected patients with an AUC of 0.95, recall (sensitivity) of 0.96. Moreover, our model could localize the main lesion features, especially the ground-glass opacity (GGO) that is of great help to assist doctors in diagnosis. The diagnosis for a patient could be finished in 30 seconds, and the implementation on Tianhe-2 supercompueter enables a parallel executions of thousands of tasks simultaneously. An online server is available for online diagnoses with CT images by http://biomed.nscc-gz.cn/server/Ncov2019.Conclusions The established models can achieve a rapid and accurate identification of COVID-19 in human samples, thereby allowing identification of patients.Competing Interest StatementThe authors have declared no competing interest.Clinical TrialNo clinical trials involveFunding StatementThe work was supported in part by the National Key R&D Program of China (2018YFC0910500), National Natural Science Foundation of China (U1611261, 61772566, and 81801132), Guangdong Frontier & Key Tech Innovation Program (2018B010109006 and 2019B020228001), Natural Science Foundation of Guangdong, China (2019A1515012207), and Introducing Innovative and Entrepreneurial Teams (2016ZT06D211).Author DeclarationsAll relevant ethical guidelines have been followed; any necessary IRB and/or ethics committee approvals have been obtained and details of the IRB/oversight body are included in the manuscript.YesAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesTo avert any potential breach of confidentiality, no link between the patients and the researchers were made available. http://biomed.nscc-gz.cn/server/Ncov2019